Clinical trial
GLucose Monitoring Programme SingaporeE (GLiMPSE) - Phase 1
NCT03837262 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GLucose Monitoring Programme SingaporeE (GLiMPSE) - Phase 1
- Lead sponsor
- Singapore General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 25, 2019
- Completion date
- April 30, 2020
- Enrollment
- 35 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.